NM_000169.3(GLA):c.437del (p.Pro146fs) AND Fabry disease

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Jul 24, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001382760.9

Allele description [Variation Report for NM_000169.3(GLA):c.437del (p.Pro146fs)]

NM_000169.3(GLA):c.437del (p.Pro146fs)

Genes:

RPL36A-HNRNPH2:RPL36A-HNRNPH2 readthrough [Gene - HGNC]
GLA:galactosidase alpha [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

Xq22.1

Genomic location:

Preferred name:

NM_000169.3(GLA):c.437del (p.Pro146fs)

HGVS:

NC_000023.11:g.101401744del
NG_007119.1:g.11222del
NM_000169.3:c.437delMANE SELECT
NM_001199973.2:c.300+6287del
NM_001199974.2:c.177+9922del
NM_001406747.1:c.560del
NM_001406748.1:c.437del
NM_001406749.1:c.560del
NP_000160.1:p.Pro146Leufs
NP_000160.1:p.Pro146fs
NP_001393676.1:p.Pro187fs
NP_001393677.1:p.Pro146fs
NP_001393678.1:p.Pro187fs
LRG_672t1:c.435del
LRG_672:g.11222del
LRG_672p1:p.Pro146Leufs
NC_000023.10:g.100656730del
NC_000023.10:g.100656732del
NM_000169.2:c.435delC
NR_164783.1:n.459del
NR_176252.1:n.459del
NR_176253.1:n.459del

Protein change:

P146fs

Links:

dbSNP: rs2147477659

NCBI 1000 Genomes Browser:

rs2147477659

Molecular consequence:

NM_000169.3:c.437del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001406747.1:c.560del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001406748.1:c.437del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001406749.1:c.560del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001199973.2:c.300+6287del - intron variant - [Sequence Ontology: SO:0001627]
NM_001199974.2:c.177+9922del - intron variant - [Sequence Ontology: SO:0001627]
NR_164783.1:n.459del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176252.1:n.459del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176253.1:n.459del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Fabry disease
Synonyms:: ALPHA-GALACTOSIDASE A DEFICIENCY; ANDERSON-FABRY DISEASE; CERAMIDE TRIHEXOSIDASE DEFICIENCY; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0010526; MedGen: C0002986; Orphanet: 324; OMIM: 301500; Human Phenotype Ontology: HP:0001071

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001581664	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Pathogenic (Jul 24, 2020)	germline	clinical testing	PubMed (3) [See all records that cite these PMIDs] 10666480, 12175777, 28492532

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001581664

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Pathogenic
(Jul 24, 2020)

germline

clinical testing

PubMed (3)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease.

Topaloglu AK, Ashley GA, Tong B, Shabbeer J, Astrin KH, Eng CM, Desnick RJ.

Mol Med. 1999 Dec;5(12):806-11.

PubMed [citation]

PMID:: 10666480
PMCID:: PMC2230489

Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype.

Shabbeer J, Yasuda M, Luca E, Desnick RJ.

Mol Genet Metab. 2002 May;76(1):23-30.

PubMed [citation]

PMID:: 12175777

See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001581664.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in GLA are known to be pathogenic (PMID: 10666480, 12175777). This variant has been observed in individual(s) with clinical features of Fabry disease (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Pro146Leufs*19) in the GLA gene. It is expected to result in an absent or disrupted protein product.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 16, 2025

ClinVar

Relating variation to medicine